There are evidences suggesting that EGFR-TKI may have an immunostimulatory effect by potentiating the induction of antigen presenting proteins in response to interferon-γ and enhancing T cells or NK cells mediated tumor killing (40–43). Here, PROS1 is linked to neoplasm.